Antibody-Based Protection of Gnotobiotic Piglets Infected with Escherichia coli O157:H7 against Systemic Complications Associated with Shiga Toxin 2

AUTOR(ES)

Donohue-Rolfe, Art

FONTE

American Society for Microbiology

RESUMO

Hemolytic-uremic syndrome (HUS) is a serious disease in children, attributable in the majority of cases to infection with Shiga toxin (Stx)-producing Escherichia coli. Using gnotobiotic piglets orally infected with E. coli O157:H7, which develop Stx-related cerebellar lesions and fatal neurological symptoms, we show that administration of Stx2-specific antiserum well after challenge protected, in a dose-response fashion, against these symptoms for at least 24 h after bacterial challenge. Twenty-six of 30 piglets given Stx2 antiserum survived the challenge, compared to only 4 of 16 animals given control serum or saline. Given our observations in piglets, Stx antibody of human origin may likewise prevent HUS in children.

Documentos Relacionados

• Colonization of Gnotobiotic Piglets by a luxS Mutant Strain of Escherichia coli O157:H7
• Human Stx2-Specific Monoclonal Antibodies Prevent Systemic Complications of Escherichia coli O157:H7 Infection
• Survival of Shiga toxin-producing Escherichia coli O157:H7 in Minas frescal cheese
• Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7.
• Probiotic Bifidobacteria Protect Mice from Lethal Infection with Shiga Toxin-Producing Escherichia coli O157:H7